Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Just Biotherapeutics

Just Biotherapeutics?uq=UG6efJS6
2014 FOUNDED
PRIVATE STATUS
71-80 EMPLOYEES
Series A2 LATEST DEAL TYPE
$14M LATEST DEAL AMOUNT
9 INVESTORS
Description

Operator of integrated design company focused on technologies that will accelerate development of biotherapeutics and substantially reduce their manufacturing cost. The company's core strengths are molecular design, process and product design and manufacturing plant design. In addition, they offer a suite of biotherapeutic research and development services, leveraging a fully integrated technology platform, delivering lasting value to clients by creating access to important biologics in a global marketplace.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Primary Office
  • South Lake Union
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Just Biotherapeutics’s full profile, request a free trial.

Just Biotherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A2) 25-Jul-2016 $14M 0000 0000 Completed Startup
2. Grant 06-Nov-2015 00.00 0000 Completed Startup
1. Early Stage VC (Series A) 18-Sep-2015 $15M $15M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Just Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table, request access »

Just Biotherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Heda Ventures Venture Capital Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Bank of China PE-Backed Company Minority 000 0000 000000 0
BOCGI Zheshang Investment Fund Management (Zhejiang) PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Just Biotherapeutics Executive Team (15)

Name Title Board
Seat
Contact
Info
James Thomas Ph.D Co-Founder, Chief Executive Officer & Board Member
Victor Fung Co-Founder, Chief Operating Officer & Board Member
Dean Pettit Ph.D Co-Founder & Chief Scientific Officer
Carolina Rizo Ph.D Chief Business Officer
James Leung Ph.D Executive Vice President for Recombinant Proteins

1 Former Executive

You’re viewing 5 of 15 executives. Get the full list »

Just Biotherapeutics Board Members (10)

Name Representing Role Since Contact
Info
Charles Cooney Ph.D Self Board Member 000 0000
Hingge Hsu MD Self Board Member 000 0000
James Thomas Ph.D Just Biotherapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Judith Li Lilly Asia Ventures Board Member 000 0000
Khoo Shih Ph.D Temasek Holdings Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »